arrow_back Search

EFTA01519389

DOJ Epstein Files
folder Dataset 10 insert_drive_file EFTA01519389.pdf description PDF text_fields 115 words · 0.9k chars
open_in_new View original source

GHISLAINE MAXWELL - OAP 1HD ACCT. For the Period 2/1/14 to 2/28/14 Equity Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation EAFE Equity 1,847,938.92 137 528 10 Market Value/Cost Current Penod Value Market Value 137,528.10 Tax Cost 132,686.12 Unrealized Gain/Loss 4,841.98 Estimated Annual Income 5,106.04 Accrued Dividends 12,566.34 Yield 3.71% Equity Detail (1,710,410.82) 100% Adjusted Tax Cost Unrealized Est. Annual Inc Pike Quantity Value Original Cost Gain/Loss Accrued Div. Yield EAFE Equity ASTRAZENECA PLC 67.76 0.00 4.13% SPONS ADR 824.15 046353.108 AZN GLAXOSINDIKUNE PLC 55.94 0.00 4 41% SPONS ADR 684.77 37733W-10.5 GSK JP Morgan Page 4 of 15 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046675 SDNY_GM_00315873 EFTA01519389